首页> 外文期刊>Nutrition Research >The effects of perioperative oral enteral support with glutamine-added elemental formulas in patients with gastrointestinal cancers. A prospective, randomized, clinical study
【24h】

The effects of perioperative oral enteral support with glutamine-added elemental formulas in patients with gastrointestinal cancers. A prospective, randomized, clinical study

机译:谷氨酰胺添加元素配方对围手术期口服肠内支持对胃肠道癌症患者的影响。前瞻性随机临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

In this clinical, prospective and randomized study, the effects of oral nutritional support in the preoperative and postoperative period of 32 patients with gastrointestinal (GI) system cancer in respect of anthropometric and plasma protein level measures were studied at the 4th Surgical Department of the Ankara Numune Research and Education Hospital. In addition to hospital diet, 33.0% of the daily energy requirements was covered with polymeric enteral formulas (Ensure(R)) in the control group (n = 16), and with glutamine enriched elemental formulas (Alitraq(R)) in the study group (n = 16). Patients had these regimens 7 days in the preoperative period and 10 days in the postoperative period. The effects of additional enteral feeding support on anthropometric and plasma protein levels in the preoperative (days I and 7) and postoperative (days I and 10) periods were assessed. In both groups, no differences were observed among the anthropometric assessments, except for the "Nutritional Risk Index". Total protein, albumin, transferrin, prealbumin, NRI, and nutritional prognostic index were affirmatively affected by both enteral formulas. However, the increments of these parameters were higher and more significant in the study group. Energy, protein, carbohydrate and lipid consumption of the patients were managed as the referred amounts. Pre- and post-operative nutritional support with glutamine enriched enteral formulas had beneficial effects on the patients with GI cancers.
机译:在这项临床,前瞻性和随机研究中,在安卡拉市第四外科部门研究了32名胃肠道(GI)系统癌症患者术前和术后口服营养支持对人体测量和血浆蛋白水平测量的影响。 Numune研究与教育医院。除医院饮食外,对照组(n = 16)的33.9%的每日能量需求已通过聚合物肠溶配方(Ensure®)和研究中的谷氨酰胺富集的元素配方(Alitraq®)覆盖。组(n = 16)。患者在术前7天和术后10天接受了这些治疗方案。评估了术前(第1天和第7天)和术后(第1天和第10天)额外的肠内喂养支持对人体测量和血浆蛋白水平的影响。在两组中,除“营养风险指数”外,人体测量学评估均未观察到差异。总蛋白,白蛋白,转铁蛋白,前白蛋白,NRI和营养预后指数均受两种肠内配方的肯定影响。但是,这些参数的增量在研究组中更高且更显着。将患者的能量,蛋白质,碳水化合物和脂质消耗作为参考量进行管理。富含谷氨酰胺的肠溶制剂的术前和术后营养支持对胃肠道癌患者具有有益的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号